Development and characterization of palbociclib-loaded PLGA nanobubbles for targeted cancer therapy
Annales Pharmaceutiques Françaises · 2025
DOI: 10.1016/j.pharma.2024.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2025. Verfasst von Boddu Kishore Kumar und 1 weiteren Autor:innen. Beteiligte Einrichtung: GITAM School of Pharmacy, GITAM Deemed to be University, 502329 Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Pyridines, Piperazines, Polylactic Acid-Polyglycolic Acid Copolymer, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: GITAM.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GITAM School of Pharmacy, GITAM Deemed to be University, 502329 Hyderabad, Telangana, India.
- GITAM School of Pharmacy, GITAM Deemed to be University, 502329 Hyderabad, Telangana, India. Electronic address: shivakumar.gubbiyappa@gitam.edu.
Förderung
- GITAM
Zitieren
APA
Kumar, B. K., & Kumar, G. S. (2025). Development and characterization of palbociclib-loaded PLGA nanobubbles for targeted cancer therapy. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.09.005
Vancouver
Kumar BK, Kumar GS. Development and characterization of palbociclib-loaded PLGA nanobubbles for targeted cancer therapy. Annales Pharmaceutiques Françaises. 2025. doi:10.1016/j.pharma.2024.09.005
BibTeX
@article{Kumar2025,
author = {Kumar, Boddu Kishore and Kumar, Gubbiyappa Shiva},
title = {Development and characterization of palbociclib-loaded PLGA nanobubbles for targeted cancer therapy},
journal = {Annales Pharmaceutiques Françaises},
year = {2025},
doi = {10.1016/j.pharma.2024.09.005}
}
EUVIMED